ABOUT ELITE
PRODUCTS
PIPELINE
- Generic
- Branded
TECHNOLOGY
INVESTOR RELATIONS

HOME | CAREERS | CONTACT | NEWS |

Skip to content

About Elite
Products
Pipeline
- Generic
- Branded
Technology
Investor Relations

Press Releases

Select:

Sep 09, 2014 Elite Pharmaceuticals Releases Positive Top Line Human Abuse Liability Data For Eli-200, An Opioid Abuse Deterrent Product

Sep 03, 2014 Elite Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference In New York City September 8-10th

Aug 14, 2014 Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2015

Aug 13, 2014 Elite Pharmaceuticals, Inc. to Host Quarterly Business Update Call on August 18, 2014

Apr 22, 2014 Elite Pharmaceuticals Granted New Patent For Abuse Deterrent Technology

Apr 14, 2014 Elite Pharmaceuticals Secures Funding Commitment Of Up To $40 Million From Lincoln Park Capital, LLC

Mar 27, 2014 Elite Pharmaceuticals Appoints Barbara Ellison as Vice President of Quality Operations and Regulatory Affairs

Mar 24, 2014 Elite Pharmaceuticals Announces Supplemental Application for Site Transfer of Isradipine

Mar 10, 2014 Elite Pharmaceuticals Expands Abuse Deterrent Technology Patent Portfolio Internationally

Feb 18, 2014 Elite Pharmaceuticals Reports Results of Pilot Bioequivalence Study for ELI-201

11 12 13 14 15 16 17 18 19 20 21

<< < > >>

Site Map | Privacy | Terms Of Use

Copyright © Elite Pharmaceuticals Inc. | All Rights Reserved.

ART™: Abuse-Resistant Technology for a safer healthier you.

Resize Viewer - Reduce

Resize Viewer - Expand